Updates in the Systemic Therapy Options for Clear Cell and Non-Clear Cell Renal Cell Carcinoma

被引：0

作者：

Spiess, Philippe E. ^{[1
]}

Johnstone, Peter A. S. ^{[1
]}

Jonasch, Eric ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd,Unit 1374, Houston, TX 77030 USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2023年 / 21卷 / 5.5期

关键词：

D O I：

10.6004/jnccn.2023.5020

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

At the NCCN 2023 Annual Conference, experts reviewed clinical data on established therapies for patients with metastatic renal cell carcinoma and discussed strategies to effectively manage both clear cell and non-clear cell tumor histologies in the setting of advanced stages. Depicted through 3 separate case studies, they strategized the selection of optimal first-line and subsequent-line therapies based on the individual case study and the tumor characteristics in each.

引用

页数：4

共 50 条

[31] Clinical outcomes of checkpoint inhibitors in metastatic non-clear cell renal cell carcinoma and clear cell renal cell carcinoma with variant features.
Chang, Guy vin
Ellithi, Moataz
Elnair, Radowan
Bleeker, Jonathan
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[32] Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula
Kopp, Ryan P.
Aganovic, Lejla
Palazzi, Kerrin L.
Cassidy, Fiona H.
Sakamoto, Kyoko
Derweesh, Ithaar H.
CANADIAN JOURNAL OF UROLOGY, 2013, 20 (03) : 6790 - 6797
[33] Morphological features and prognosis of non-clear cell renal cell carcinoma types
Zakharava, V.
Liatkouskaya, T.
Kiselev, P.
Cherstvoy, E.
Lapec, A.
VIRCHOWS ARCHIV, 2018, 473 : S335 - S336
[34] Systematic Review of Treatment of Metastatic Non-Clear Cell Renal Cell Carcinoma
Brown, Jason R.
Calaway, Adam
Castle, Erik
Garcia, Jorge
Barata, Pedro C.
KIDNEY CANCER, 2022, 6 (01) : 53 - 68
[35] EFFICACY AND SAFETY OF SUNITINIB IN PATIENTS WITH NON-CLEAR CELL RENAL CELL CARCINOMA
Lee, J. -L.
Ahn, J. -H.
Park, S. H.
Lim, H. Y.
Lee, S. H.
Kim, T. -M.
Cho, Y. -M.
Song, C.
Hong, J. H.
Kim, C. -S.
Ahn, H.
ANNALS OF ONCOLOGY, 2012, 23 : 141 - 141
[36] Current treatment approach to non-clear cell renal carcinoma
Timofeev, I. V.
ONKOUROLOGIYA, 2015, 11 (04): : 24 - 33
[37] Non-clear cell renal cell carcinoma (nccRCC): A Brazilian experience.
Yamamura, Rosely
Rinck, Jose A.
Fonseca Jesus, Victor Hugo
Tavares, Monique Celeste
de Castro Larclprete, Ana Luisa
Iennaco, Pietro Schettlni
Freitas, Heleno C.
Cunha, Isabela Warneck
Fanelli, Marcello Ferretti
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[38] The Role of Pazopanib in Non-Clear Cell Renal Cell Carcinoma: A Systematic Review
Sneed, Gregory T.
Lee, Sukdong
Brown, Jamie N.
Hammond, Julia M.
CLINICAL GENITOURINARY CANCER, 2019, 17 (06) : 419 - 424
[39] The genomic landscape of metastatic non-clear cell renal cell carcinoma.
Carlo, Maria Isabel
Khan, Nabeela
Chen, Yingbei
Hsieh, James
Hakimi, A. Ari
Lee, Chung-Han
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
[40] Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma
Koshkin, Vadim S.
Barata, Pedro C.
Zhang, Tian
George, Daniel J.
Atkins, Michael B.
Kelly, William J.
Vogelzang, Nicholas J.
Pal, Sumanta K.
Hsu, JoAnn
Appleman, Leonard J.
Ornstein, Moshe C.
Gilligan, Timothy
Grivas, Petros
Garcia, Jorge A.
Rini, Brian I.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6

← 1 2 3 4 5 →